QC of immune cell
QC tests
QC kits
motility of therapeutic cells
inactive therapeutic cells
tumours cells
serval millions QC
relevant therapeutic cell types
Identification of relevant QC parameters
Quality Control of Immune Cells
complete QC solution
Cell-Based Therapies Cell-based therapy
patient-specific production of therapeutic immune cells
global player of medical QC
TimeLapseReader
Phase
CBT field
medical market
standardized cell culture carriers
leading provider of live cell migration assays ibidi
key parameters
cancer types
proposal
cancer patients
reliable assessment of motility parameters
best market entry strategy
reproducible migration tests
automated instrument
patient treatment
thousands of patients
Expected impact
manufacturing facilities
new standard
disruptive innovation
years
integrated bench
feasibility study
freedom
cure of difficult
adverse effects
business plan
competitor
personalized medicine
regulatory approval
combination
CTB
slides
reagents
technology
funding
final device version
remaining risks
analysis
goal
Objectives